首页> 外国专利> Respiratory therapy method for new coronavirus infection COVID-19 in patients on artificial lung ventilation

Respiratory therapy method for new coronavirus infection COVID-19 in patients on artificial lung ventilation

机译:人工肺气通风患者新冠状病毒感染Covid-19呼吸治疗方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to resuscitation and intensive care, and can be used in respiratory therapy for new coronavirus infection (NCI) COVID-19 in patients on artificial lung ventilation. The method includes passing through the contour of an artificial respiration unit for 48 hours at a dose of 80 ppm, then reducing the dose to 40 ppm and conducting continuous inhalation until signs of acute respiratory distress syndrome are relieved. ;EFFECT: use of the invention makes it possible to improve the treatment’s effectiveness and improve the clinical outcomes in patients with NCI COVID-19, who are on artificial lung ventilation. ;1 cl, 2 ex
机译:田地:医学。物质:发明涉及医学,即复苏和密集护理,可用于人工肺通气患者的新冠状病毒感染(NCI)Covid-19的呼吸疗法。该方法包括以80ppm剂量的剂量通过人工呼吸单元的轮廓,然后将剂量降低至40ppm并进行连续吸入,直至释放急性呼吸窘迫综合征的迹象。 ;效果:使用本发明使得可以提高治疗的有效性,改善NCI Covid-19患者患者的临床结果,他是人工肺通气。 ; 1 cl,2前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号